Valuation: Elekta AB

Market Cap 21.15B 2.23B 1.91B 1.79B 1.64B 3.08B 214B 3.12B 8.25B 107B 8.39B 8.2B 355B P/E 2027 *
14.7x
P/E 2028 * 13.2x
Enterprise Value 24.58B 2.6B 2.22B 2.08B 1.9B 3.57B 248B 3.62B 9.59B 125B 9.75B 9.53B 413B EV / Sales 2027 *
1.41x
EV / Sales 2028 * 1.33x
Free-Float
-
Yield 2027 *
4.47%
Yield 2028 * 4.89%
1 day+2.17%
1 week+5.46%
Current month+16.56%
1 month+24.10%
3 months-7.47%
6 months-2.08%
Current year-3.66%
1 week 5.56
Extreme 5.565
5.88
1 month 4.63
Extreme 4.63
5.88
Current year 4.63
Extreme 4.63
6.93
1 year 4.35
Extreme 4.35
6.93
3 years 4.35
Extreme 4.35
8.62
5 years 4.35
Extreme 4.35
14.58
10 years 4.35
Extreme 4.35
15.56
Manager TitleAgeSince
Chief Executive Officer - 31/08/2025
Director of Finance/CFO - 28/02/2026
Investor Relations Contact - 30/11/2023
Director TitleAgeSince
Director/Board Member 69 29/06/2010
Director/Board Member 70 14/09/2011
Chairman 74 02/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%+5.46% - - 2.23B
-1.26%+6.91%+30.01%+18.17% 232B
+1.38%+8.34%+7.57%-12.32% 152B
+1.24%-3.90%-19.31%+32.26% 132B
+2.36%-2.73%-52.08%-0.01% 71.55B
-0.03%-1.90%+10.72%+17.73% 51.78B
+0.98%+2.97%-16.53%-11.67% 51.75B
+1.70%+7.29%+36.03%+34.08% 44.14B
+1.52%+0.08%+42.02%+54.39% 39.76B
+1.01%+1.74%+2.49%+8.70% 33.45B
Average +1.20%+0.46%+4.55%+15.70% 89.84B
Weighted average by Cap. +0.65%+1.38%+6.03%+13.46%

Financials

2027 *2028 *
Net sales 17.41B 1.84B 1.57B 1.47B 1.35B 2.53B 176B 2.56B 6.79B 88.34B 6.9B 6.75B 292B 18.14B 1.92B 1.64B 1.54B 1.41B 2.64B 183B 2.67B 7.07B 92.06B 7.19B 7.04B 304B
Net income 1.46B 154M 132M 124M 113M 212M 14.76B 215M 570M 7.41B 579M 567M 24.52B 1.63B 172M 147M 138M 126M 237M 16.44B 240M 634M 8.26B 645M 631M 27.31B
Net Debt 3.43B 362M 310M 290M 266M 499M 34.67B 506M 1.34B 17.42B 1.36B 1.33B 57.61B 2.96B 312M 267M 250M 229M 430M 29.88B 436M 1.15B 15.01B 1.17B 1.15B 49.64B
Logo Elekta AB
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
3,704
Date Price Change Volume
21/08/26 US$5.885 +2.17% 2,081
20/08/26 US$5.760 -1.20% 14,673
19/08/26 US$5.830 +4.67% 5,066
17/08/26 US$5.570 -0.19% 5,178
14/08/26 US$5.580 +3.05% 4,556
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
56.15SEK
Average target price
59.82SEK
Spread / Average Target
+6.54%

Quarterly revenue - Rate of surprise